KEMX Fees and Costs — KraneShares MSCI Emerging Markets ex China Index ETF

Data updated: 2026-08-28

The net expense ratio is 0.24%: a 0.58% management fee plus 0.01% other expenses, less a 0.35% fee waiver. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $28K in broker commissions, 0.0386% of average net assets, and portfolio turnover was 27%.

KEMX Fees and Expenses

Annual operating expenses and sales charges of KEMX. Prospectus, as of August 1, 2026.

Annual operating expenses
Management fee0.58%
12b-1 fee0.00%
Other expenses0.01%
Gross expense ratio0.59%
Fee waiver−0.35%
Net expense ratio0.24%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentNo

KEMX Costs Over Time

On $10,000 invested in KEMX, assuming 5% a year before costs, total costs come to $177 over 5 years, cutting the return by 0.29% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.24%)$25$79$138
Trading costs (broker commissions)$4$13$22
Lost growth on money paid in costs$0$5$16
Total costs$29$96$177
Value after costs$10,471$11,480$12,586
Impact on return, per year0.29%0.29%0.29%

KEMX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2026.

  • Explicit cost rate (commissions ÷ average net assets): 0.0386%
  • Total broker commissions: $28K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 27%
  • Securities lending: none during the year

KEMX Agency Brokers

Commissions paid.

BrokerAmountShare
J P MORGAN CHASE BANK$24K85.34%
BAML$4K14.66%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.